Sol-Gel Technologies Ltd. (SLGL)
NASDAQ·Healthcare·Biotechnology
$71.96
-6.55%
Mkt Cap $233.45M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $6.50M | $6.50M | +0.00% | $0.39 | -$1.07 | -374.36% | — | — |
| Q4 2025 Nov 20, 2025 | $6.50M | $400.00K | -93.85% | -$2.09 | -$2.13 | -1.91% | — | — |
| Q3 2025 Aug 15, 2025 | $2.86M | $17.26M | +504.00% | -$0.67 | $4.17 | +722.39% | — | — |
| Q2 2025 Apr 29, 2025 | $2.00M | $1.03M | -48.45% | -$1.10 | -$2.10 | -90.91% | — | — |
| Q1 2025 Mar 26, 2025 | $2.00M | $278.00K | -86.10% | -$0.11 | -$0.21 | -90.77% | — | — |
| Q4 2024 Nov 15, 2024 | $2.00M | $5.36M | +168.05% | -$0.13 | -$0.01 | +92.31% | — | — |
| Q3 2024 Aug 16, 2024 | $1.05M | $5.43M | +417.43% | -$0.20 | $0.07 | +135.00% | — | — |
| Q2 2024 May 20, 2024 | $930.00K | $466.00K | -49.89% | -$0.15 | -$0.23 | -53.33% | — | — |
| Q1 2024 Mar 13, 2024 | $270.00K | $447.00K | +65.56% | -$0.16 | -$0.17 | -6.25% | — | — |
| Q4 2023 Nov 9, 2023 | $270.00K | $213.00K | -21.11% | -$0.23 | -$0.21 | +8.70% | — | — |
| Q3 2023 Aug 10, 2023 | $1.55M | $594.00K | -61.68% | -$0.26 | -$0.22 | +15.38% | — | — |
| Q2 2023 May 12, 2023 | $470.00K | $758.00K | +61.28% | -$0.22 | -$0.41 | -86.36% | — | — |
| Q1 2023 Mar 10, 2023 | $1.84M | $100.00K | -94.57% | -$0.13 | -$0.25 | -92.31% | — | — |
| Q4 2022 Nov 10, 2022 | $3.42M | $261.00K | -92.38% | -$0.07 | -$0.15 | -114.29% | — | — |
| Q3 2022 Aug 4, 2022 | $4.61M | $3.52M | -23.68% | -$0.10 | -$0.01 | +90.00% | — | — |
| Q2 2022 May 13, 2022 | $1.37M | $3.00K | -99.78% | -$0.30 | -$0.24 | +20.00% | — | — |
| Q1 2022 Mar 30, 2022 | $17.65M | $20.81M | +17.86% | $0.41 | $0.61 | +48.78% | — | — |
| Q4 2021 Nov 11, 2021 | $23.86M | $8.84M | -62.96% | -$0.07 | $0.05 | +171.43% | — | — |
| Q3 2021 Aug 4, 2021 | $861.30K | $928.00K | +7.74% | -$0.20 | -$0.35 | -75.00% | — | — |
| Q2 2021 May 13, 2021 | $1.01M | $701.00K | -30.56% | -$0.49 | -$0.18 | +63.27% | — | — |